Extendicare (EXE) Stock Chart & Stock Price History C$14.06 +0.26 (+1.88%) As of 05/1/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesBuy This Stock Extendicare Stock Price Performance 5 Day Performance+5.32%1 Month Performance+5.71%3 Month Performance+35.85%6 Month Performance+55.19%Year-To-Date Performance+32.27%1 Year Performance+89.74% Receive EXE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address EXE Stock Chart for Friday, May, 2, 2025 EXE Chart by TradingView Extendicare Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025C$13.80C$14.06+1.88%C$14.20C$13.76215,306 shsC$1.17 billion04/30/2025C$13.70C$13.80+0.73%C$13.86C$13.56270,478 shsC$1.15 billion04/29/2025C$13.43C$13.70+2.01%C$13.75C$13.42236,785 shsC$1.14 billion04/28/2025C$13.35C$13.43+0.60%C$13.43C$13.2787,979 shsC$1.12 billion04/25/2025C$13.29C$13.35+0.45%C$13.35C$13.1879,195 shsC$1.11 billion04/24/2025C$13.02C$13.29+2.07%C$13.34C$12.97160,625 shsC$1.11 billion04/23/2025C$13.05C$13.02-0.23%C$13.22C$12.9991,012 shsC$1.09 billion04/22/2025C$13.12C$13.05-0.53%C$13.25C$12.99180,793 shsC$1.09 billion04/21/2025C$13.24C$13.12-0.91%C$13.28C$13.0493,211 shsC$1.10 billion04/18/2025C$13.24C$13.24C$13.30C$13.1192,658 shsC$1.11 billion Get the Latest News and Ratings for EXE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025C$13.23C$13.24+0.08%C$13.30C$13.1192,658 shsC$1.11 billion04/16/2025C$13.31C$13.23-0.60%C$13.28C$13.1394,868 shsC$1.10 billion04/15/2025C$12.94C$13.31+2.86%C$13.33C$12.83247,543 shsC$1.11 billion04/14/2025C$12.95C$12.94-0.08%C$13.18C$12.89168,261 shsC$1.08 billion04/11/2025C$12.99C$12.95-0.31%C$13.18C$12.85182,941 shsC$1.08 billion04/10/2025C$12.92C$12.99+0.54%C$13.04C$12.67193,086 shsC$1.08 billion04/09/2025C$12.65C$12.92+2.13%C$12.98C$12.36209,893 shsC$1.08 billion04/09/2025C$12.65C$12.92+2.13%C$12.98C$12.36209,893 shsC$1.08 billion04/08/2025C$12.76C$12.65-0.86%C$13.08C$12.54165,499 shsC$1.06 billion04/08/2025C$12.76C$12.65-0.86%C$13.08C$12.54165,499 shsC$1.06 billion04/07/2025C$13.10C$12.76-2.60%C$13.10C$12.51302,610 shsC$1.07 billion04/04/2025C$13.05C$13.10+0.38%C$13.17C$12.74299,369 shsC$1.09 billion04/03/2025C$13.30C$13.05-1.88%C$13.31C$13.00143,357 shsC$1.09 billion04/02/2025C$13.00C$13.30+2.31%C$13.31C$12.94261,885 shsC$1.11 billion04/01/2025C$12.90C$13.00+0.78%C$13.11C$12.78170,515 shsC$1.09 billion Related Companies dentalcorp Stock Price Chart Sienna Senior Living Stock Price Chart WELL Health Technologies Stock Price Chart Medical Facilities Stock Price Chart KDA Group Stock Price Chart Nova Leap Health Stock Price Chart Premier Health of America Stock Price Chart Bausch Health Companies Stock Price Chart Cronos Group Stock Price Chart Knight Therapeutics Stock Price Chart Receive EXE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:EXE) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Extendicare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
